IGC → $4.13 by May 22, 2028.

Not financial advice. Always do your own research. IGC Pharma — Analyst Ratings & Price Targets Coverage is limited but fully bullish. Only 2 Wall Street analysts actively cover $IGC, and both carry Buy ratings. Ascendiant Capital Markets Rating: Buy Price Target: $5.25 Date: April 8, 2026 Alliance Global Partners (AGP) Rating: Buy Price Target: $3.00 Date: February 10, 2026 Consensus: 2 Buy | 0 Hold | 0 Sell Average Price Target: \~$4.13 Target Range: $3.00 – $5.25 Current Price: …